English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessMarketsA golden goose gone: Why Glenmark Pharma’s investors are unhappy with Nirma deal

    A golden goose gone: Why Glenmark Pharma’s investors are unhappy with Nirma deal

    Glenmark Pharma has hived off a 75 percent stake in Glenmark Life Sciences, which accounted for nearly 11 percent of its consolidated top line, and had a 20 percent EBITDA contribution, to clear debt

    Vaibhavi Ranjan
    September 25, 2023 / 14:25 IST
    A golden goose gone: Why Glenmark Pharma’s investors are unhappy with Nirma deal

    The stake sale, done at reasonable valuations, will help Glenmark Pharma turn debt-free.

    • PRO Panorama

      Moneycontrol Pro Panorama | How to be long term greedy

      Sep 5, 2025 / 03:14 PM IST

      For September 5 edition of Moneycontrol Pro Panorama: Flood-hit Punjab spells bad news for food security, caution for borrowers as...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts